Reverse Convertible Bond 8 % Health Care Aktienanleihe The product related information contained herein is exclusively for information purposes only, intended for current investors or in case these products are displayed further to an individual search. The information does not constitute a recommendation or an offer to buy or an invitation to make a respective offer in relation to any of the products described herein.
Change+0.110 (+0.18%) Bid62.72% Ask64.22% Last updateDec 02, 2022
08:15:22.250
UTC
Barrier- StrikeEUR 100.00 Max. profit p.a.60.03% Interest rate p.a.8.00%
Name
Reverse Convertible Bond on Worst of Basket
ISIN / WKN
AT0000A2VXR8 / RC05Y0
Underlying
Max. profit in %
80.63%
Max. profit p.a. in %
60.03%
Interest rate whole maturity
-
Interest rate p.a.
8.00%
Underlying price
-
Starting value
EUR 100.00
Strike
EUR 100.00
Distance to strike in %
-
Distance Barrier
-
Barrier reached
yes (Barrier: EUR 59.00)
Number of shares
-
Denomination / nominal
EUR 1,000
About the term
Initial valuation date
Apr 05, 2022
Issue date
Apr 06, 2022
Final valuation date
Apr 03, 2024
Maturity date
Apr 08, 2024
Product classification
Investment Product without Capital Protection
Security type (eusipa Nr.)
Reverse Convertible Bond (1230)
Reverse Convertible Bond Type
Barrier Reverse Convertible Bonds
Underlying
Country / region of underlying
-
Suited market expectation
sideways, bullish
Observation barrier
Closing Price
Issue price
100.00%
Spread homogenised
-
Spread in %
2.39%
Multiplier
-
Product currency
EUR
Underlying currency
-
Settlement method
Cash settlement / Physical delivery
Tax treatment
Capital Gains Tax / EU Withholding Tax
Public offer in
Austria, Germany, Italy, Hungary, Poland, Czech Republic, Slovakia, Bulgaria, Croatia, Romania, Slovenia
Listing
Vienna, Frankfurt, Stuttgart
Comments

The 8% Health Care Reverse Convertible Bond is redeemed at 100% nominal value at the maturity date (April 2024), provided that, during the observation period, the closing price of each of the three underlying shares (Fresenius SE & Co. KGaA, Koninklijke Philips N.V. and Sanofi S.A.) always quoted above the barrier of 59% of the strike (daily observation). The interest amount of 8% is paid out annually, regardless of the performance of the underlying shares.In case the barrier is touched or undercut by at least one of the underlying shares and at least one of the underlying shares quotes below its strike at the final valuation date, the predefined amount of the worst performing share will be delivered. If all three underlying shares quote at or above their strike at the final valuation date, the product is redeemed at 100% nominal value despite a barrier event.

The barrier has been touched by Koninklijke Philips NV on September 1, 2022